Becker's Healthcare January 8, 2025
Glucagon-like peptide-1 receptor agonist drugs may reduce the risk of surgical complications in diabetic patients, according to a large new study.
The study showed diabetic patients taking GLP-1 drugs, such as semaglutide and tirzepatide, faced significantly lower risks of 30-day readmission, wound re-opening and hematoma after surgery, compared to patients with diabetes who were not using the medications.
Researchers from Weill Cornell Medicine, Columbia University and NewYork-Presbyterian, all based in New York City, evaluated de-identified EHR data for nearly 22,000 patients with diabetes who underwent 74,425 surgical procedures between February 2020 to July 2023. The findings were published Dec. 20 in Annals of Surgery, showing the cohort of patients taking GLP-1 drugs experienced a:
- 12%...
Today's Sponsors
Today's Sponsor